Sonoma Pharmaceuticals
SNOA
S$4.22
Share price
-4.09%
Change (1 day)
-49.34%
Change (1 year)
Categories
P/S ratio for Sonoma Pharmaceuticals (SNOA)
P/S ratio as of July 2025 (TTM): 0.3771
According to Sonoma Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.22. At the end of 2025 the company had a P/S ratio of 0.2725.
P/S ratio history for Sonoma Pharmaceuticals from 2007 to 2025
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2025 | 0.2725 | 3.41% |
| 2024 | 0.2636 | 31.47% |
| 2023 | 0.2005 | -27.64% |
| 2022 | 0.2771 | -75.52% |
| 2021 | 1.13 | 57.85% |
| 2020 | 0.7170 | 66.53% |
| 2019 | 0.4306 | -7.92% |
| 2018 | 0.4676 | -66.82% |
| 2017 | 1.41 | -18.18% |
| 2016 | 1.72 | 22.6% |
| 2015 | 1.40 | 45.05% |
| 2014 | 0.9685 | -45.84% |
| 2013 | 1.79 | 21.43% |
| 2012 | 1.47 | -36.9% |
| 2011 | 2.33 | -51.6% |
| 2010 | 4.82 | -30.09% |
| 2009 | 6.90 | 104.31% |
| 2008 | 3.38 | -70.66% |
| 2007 | 11.5 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Onconova Therapeutics ONTX | 92.5 | 24,427.83% | 🇺🇸 USA |
 OPKO Health
OPK | 1.55 | 311.80% | 🇺🇸 USA |